NRG1 Human shRNA Plasmid Kit (Locus ID 3084)
Specifications
| Product Data | |
| Locus ID | 3084 |
|---|---|
| Synonyms | ARIA; GGF; GGF2; HGL; HRG; HRG1; HRGA; MST131; MSTP131; NDF; NRG1-IT2; SMDF |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol (34 ug/ml) |
| Mammalian Cell Selection | Puromycin |
| Format | Lentiviral plasmids |
| Components | NRG1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 3084). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
| RefSeq | NM_001159995, NM_001159996, NM_001159999, NM_001160001, NM_001160002, NM_001160004, NM_001160005, NM_001160007, NM_001160008, NM_001322197, NM_001322201, NM_001322202, NM_001322205, NM_001322206, NM_001322207, NM_004495, NM_013956, NM_013957, NM_013958, NM_013959, NM_013960, NM_013961, NM_013962, NM_013964, NM_013962.1, NM_013962.2, NM_013964.1, NM_013964.2, NM_013964.3, NM_013964.4, NM_013956.1, NM_013956.2, NM_013956.3, NM_013956.4, NM_013957.1, NM_013957.2, NM_013957.3, NM_013957.4, NM_013960.1, NM_013960.2, NM_013960.3, NM_013960.4, NM_004495.1, NM_004495.2, NM_004495.3, NM_013959.1, NM_013959.2, NM_013959.3, NM_013958.1, NM_013958.2, NM_013958.3, NM_001160007.1, NM_001160002.1, NM_001160005.1, NM_001159996.1, NM_001159996.2, NM_001160008.1, NM_001160004.1, NM_001160004.2, NM_001160001.1, NM_001160001.2, NM_001159995.1, NM_001159995.2, NM_001159999.1, NM_001159999.2, NM_013961.2, BC006492, BC007675, BC064587, BC073871, BC144446, BC150609, NM_001322203, NM_001160008.2, NM_001160004.3, NM_004495.4, NM_001160007.2, NM_001159995.3, NM_001159999.3, NM_001160001.3, NM_013960.5, NM_013957.5, NM_001160002.2, NM_013964.5, NM_013956.5 |
| UniProt ID | Q02297 |
| Summary | The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). provided by RefSeq, Apr 2016 |
| shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
| Storage | Store at -20°C |
| Shipping | Ambient |
Reviews
Documents
Resources
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.